Gardasil sBLA given priority review
March 19 2008
Merck said today that the FDA has granted priority review status to the company's supplemental Biologics License Application (sBLA) for ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.